Healthcare - Biotechnology - NASDAQ - US
$ 15.39
-5.81 %
$ 779 M
Market Cap
-9.22
P/E
BALANCE SHEET
226 M
ASSETS
21.6 M
LIABILITIES
204 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Tyra Biosciences, Inc.
| Current Assets | 212 M |
| Cash & Short-Term Investments | 203 M |
| Receivables | 0 |
| Other Current Assets | 8.2 M |
| Non-Current Assets | 14.2 M |
| Long-Term Investments | 0 |
| PP&E | 8.15 M |
| Other Non-Current Assets | 6.03 M |
| Current Liabilities | 15.3 M |
| Accounts Payable | 4.66 M |
| Short-Term Debt | 560 K |
| Other Current Liabilities | 10.1 M |
| Non-Current Liabilities | 6.26 M |
| Long-Term Debt | 6.22 M |
| Other Non-Current Liabilities | 46 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 58.0 | 251.2 | 302.2 | 15.2 | 0.1 |
| Short Term Investments | 145.5 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.2 | 6.1 | 3.8 | 57 K | 19 K |
| Total Current Assets | 211.7 | 257.3 | 304.1 | 15.3 | 0.1 |
| PP&E | 8.2 | 3.5 | 2.1 | 0.5 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.0 | 0.2 | 0.2 | 0 |
| Other Long Term Assets | 6.0 | 4.3 | 0.6 | 21 K | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 225.9 | 266.2 | 306.7 | 16.0 | 0.5 |
| LIABILITIES | |||||
| Accounts Payable | 4.7 | 1.1 | 0.6 | 0.7 | 0.3 |
| Short Term Debt | 0.6 | 0.3 | 0.4 | 0.1 | 0.1 |
| Other Current Liabilities | 10.1 | 4.3 | 2.6 | 1.1 | 4.7 |
| Total Current Liabilities | 15.3 | 5.7 | 3.6 | 1.9 | 5.2 |
| Long Term Debt | 6.2 | 2.5 | 1.0 | 0 | 0.1 |
| Deferred Tax Income | 0 | 0 | 0.3 | 0 | 0 |
| Other Liabilities | 46 K | 0.2 | 0.4 | 27.8 | 0 |
| Total Liabilities | 21.6 | 8.4 | 5.0 | 29.6 | 5.3 |
| EQUITY | |||||
| Common Stock | 4 K | 4 K | 4 K | 0 | 0 |
| Retained Earnings | (164.8) | (95.7) | (40.4) | (14.1) | (4.7) |
| Other Accumulative Comprehensive Income/Loss | 0.4 | 0 | (306.7) | 0 | 0 |
| Total Equity | 204.3 | (95.7) | 301.7 | (13.6) | (4.7) |
| Total Liabilities and Equity | 225.9 | (87.3) | 306.7 | 16.0 | 0.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 42.7 | 41.9 | 41.4 | 42.5 | 42.5 |